Answers are grounded in this paper and cite their sources.
Our study shows the safety and biological activity of Etanercept in breast cancer and provides data to assess pharmacodynamic endpoints of different schedules of Etanercept and combinations with chemotherapy or other biological therapies.
No takes yet. Share an insight, caveat, or question.
Madhusudan et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: